Vertex Wins Approval for Kalydeco to Treat Cystic Fibrosis

Vertex Pharmaceuticals Inc. won approval of the first drug to treat the underlying cause of cystic fibrosis.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.